During the past decade, Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza" #1 collaborator was "Clirest s.r.l." with 2 trials as a collaborator, "Temas srl" with 2 trials as a collaborator, "Arithmos srl" with 1 trials as a collaborator, "Istituto Toscano Tumori" with 1 trials as a collaborator and "Mipharm S.p.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza" are "Cancer, Breast" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza" in a lesser frequency.

Most popular intervention types in "Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (1 trials), "Nabpaclitaxel" (1 trials), "Pertuzumab" (1 trials), "Trastuzumab IV" (1 trials) and "Trastuzumab SC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".